This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • BMO Capital analyst Kostas Biliouris initiated coverage on Avidity Biosciences, Inc. RNA with an Outperform rating and announced a price target of $72. Avidity Biosciences shares closed at $29.58 on Tuesday. See how other analysts view this stock.
  • B. Riley Securities analyst Yuan Zhi initiated coverage on Radiopharm Theranostics Limited RADX with a Buy rating and announced a price target of $15. Radiopharm Theranostics shares closed at $5.75 on Tuesday. See how other analysts view this stock.
  • Morgan Stanley analyst David Arcaro initiated coverage on Talen Energy Corporation TLN with an Overweight rating and announced a price target of $243. Talen Energy shares closed at $176.56 on Tuesday. See how other analysts view this stock.
  • Mizuho analyst Sean Kennedy initiated coverage on S&P Global Inc. SPGI with an Outperform rating and announced a price target of $599. S&P Global shares closed at $480.00 on Tuesday. See how other analysts view this stock.
  • Scotiabank analyst Nat Schindler initiated coverage on Upwork Inc. UPWK with a Sector Perform rating and announced a price target of $15. Upwork shares closed at $13.39 on Tuesday. See how other analysts view this stock.

Considering buying SPGI stock? Here’s what analysts think:

Today's Best Finance Deals

Read this Next:

Loading...
Loading...
RADX Logo
RADXRadiopharm Theranostics Ltd
$5.478.32%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
Not Available
Growth
Not Available
Quality
Not Available
Value
16.84
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Comments
Loading...